Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone-Reference-Cited by-同舟云学术

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

Published:2016-12 Issue:1 Volume:18 Page:36-42
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Koller Kristian M.¹,Mackley Heath B.²,Liu Jason³,Wagner Henry²,Talamo Giampaolo¹,Schell Todd D.⁴,Pameijer Colette⁵,Neves Rogerio I.⁵,Anderson Bryan⁶,Kokolus Kathleen M.⁴,Mallon Carol A.¹,Drabick Joseph J.¹

Affiliation:

1. The Division of Hematology Oncology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

2. Division of Radiation Oncology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

3. The Penn State College of Medicine, Hershey, PA, USA

4. Department of Microbiology and Immunology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

5. Department of Surgery, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

6. Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, PA, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1264543

Reference34 articles.

1. The malignant melanoma landscape

2. Melanoma

3. Ipilimumab

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors for Pediatric Cancers: Is It Still a Stalemate?;Pharmaceuticals;2024-07-26

2. Immune Response to Molecular Radiotherapy with ¹⁷⁷Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome;Cancer Biotherapy and Radiopharmaceuticals;2024-06-21

3. Previous radiotherapy increases the efficacy of cemiplimab in the treatment of locally advanced and metastatic cutaneous squamous cell carcinoma: A retrospective analysis;Journal of the American Academy of Dermatology;2024-06

4. The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results;Journal of Personalized Medicine;2024-05-29

5. Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells;Molecular Oncology;2024-05-22